UK Clinical Evidence Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management
Overall mental clarity Reducing the risk of cognitive decline as we age
In one study, Ozempic users lost almost 6 percent of their body weight after three months
Stop taking Ozempic and seek urgent medical help Persistent vomiting preventing adequate fluid intake Signs of dehydration dark urine, dizziness, reduced urination Symptoms of hypoglycaemia shakiness, sweating, confusion, rapid heartbeat Visual changes or worsening of diabetic retinopathy Signs of allergic reaction rash, swelling, difficulty breathing (call 999 for severe reactions) Most side effects improve as your body adjusts to the medication
Patients with cerebral edema have a high incidence of seizures, but prophylactic antiseizure medications such as phenytoin have not been proven to be beneficial
Without a clinician watching for warning signs, checking drug interactions, and adjusting the plan, she cautioned, serious problems can slip by unnoticed
